• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Nextcure Inc (NQ: NXTC )

    1.290 -0.030 (-2.27%)
    Streaming Delayed Price Updated: 4:00 PM EST, Nov 8, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Nextcure Inc

    < Previous 1 2 3 Next >
    NextCure to Present at the 35th Annual Piper Sandler Healthcare Conference
    From NextCure
    Via GlobeNewswire
    NextCure Publishes Non-Clinical Data Defining the Mechanism of Action for NC525, a Novel LAIR-1 Antibody for AML
    From NextCure
    Via GlobeNewswire
    NextCure Provides Business Update and Reports Third Quarter 2023 Financial Results
    From NextCure
    Via GlobeNewswire
    NextCure, LegoChem Biosciences Ink Collaborative Pact For Antibody Drug Conjugates
    Via Benzinga
    Preclinical Data Demonstrate Anti-Siglec-15 Treatment Reduced Bone Loss and Enhanced Bone Quality in Mice with Moderate-to-Severe Osteogenesis Imperfecta (OI)
    Data Presented at the 2023 American Society for Bone and Mineral Research (ASBMR) Annual Meeting 
    From NextCure
    Via GlobeNewswire
    NextCure Presents Preclinical Data on NC181, a Novel Therapeutic Candidate Targeting ApoE4, for the Treatment of Alzheimer’s Disease
    From NextCure
    Via GlobeNewswire
    A Phase 2 Study of Anti-Siglec-15 Antibody, NC318, in Combination with Pembrolizumab (NCT04699123) Demonstrates Clinical Activity in Patients with Advanced PD-1 Axis Inhibitor Refractory NSCLC
    From NextCure
    Via GlobeNewswire
    NextCure and Nordic Bioscience Publish Review Article on the Regulation of Tumor Immunity by Tumor Collagen
    From NextCure
    Via GlobeNewswire
    Preclinical Data Demonstrate Potential Application of Anti-Siglec-15 Treatment in Bone Disease
    From NextCure
    Via GlobeNewswire
    NextCure to Present at the H.C. Wainwright 25th Annual Global Investment Conference
    From NextCure
    Via GlobeNewswire
    Benzinga's Top Ratings Upgrades, Downgrades For August 8, 2023
    Via Benzinga
    NextCure Provides Business Update and Reports Second Quarter 2023 Financial Results
    From NextCure
    Via GlobeNewswire
    NextCure Presents Non-Clinical Data Defining the Mechanism of NC525 at the 2023 Federation of Clinical Immunology Societies (FOCIS) Annual Meeting
    From NextCure
    Via GlobeNewswire
    12 Health Care Stocks Moving In Tuesday's Pre-Market Session
    Via Benzinga
    NextCure to Present at the JMP Securities Life Sciences Conference
    From NextCure
    Via GlobeNewswire
    NextCure Provides Business Update and Reports First Quarter 2023 Financial Results
    From NextCure
    Via GlobeNewswire
    NextCure to Present at 22nd Annual Needham Virtual Healthcare Conference
    From NextCure
    Via GlobeNewswire
    NextCure Provides Business Update and Reports Full Year 2022 Financial Results
    From NextCure
    Via GlobeNewswire
    NextCure to Present at SVB Securities Global Biopharma Conference
    From NextCure
    Via GlobeNewswire
    Stocks That Hit 52-Week Lows On Tuesday
      On Tuesday, 89 companies set new 52-week lows. 
    Via Benzinga
    NextCure to Present at Upcoming Investor Conferences
    From NextCure
    Via GlobeNewswire
    Stocks That Hit 52-Week Lows On Monday
      On Monday, 79 companies reached new 52-week lows. 
    Via Benzinga
    NextCure and LegoChem Biosciences Enter into Collaboration and Co-Development Agreement to Develop Antibody Drug Conjugates
    From NextCure
    Via GlobeNewswire
    Stocks That Hit 52-Week Lows On Thursday
      During Thursday's session, 97 companies made new 52-week lows. 
    Via Benzinga
    12 Health Care Stocks Moving In Monday's Intraday Session
    Gainers 
    Via Benzinga
    NextCure Presents Initial Data from Clinical Trial of NC762 and a Trial in Progress Poster for NC410 Combo at the 2022 Society for Immunotherapy of Cancer Annual Meeting
    From NextCure
    Via GlobeNewswire
    Why MediaAlpha Shares Jumped Around 30%; Here Are 112 Biggest Movers From Friday
    Gainers 
    Via Benzinga
    Stocks That Hit 52-Week Lows On Friday
      Friday's session saw 236 companies set new 52-week lows. 
    Via Benzinga
    Why Yelp Shares Are Trading Lower By 15%? Here Are 86 Stocks Moving In Friday's Mid-Day Session
    Gainers 
    Via Benzinga
    NextCure Provides Update and Reports Third Quarter 2022 Financial Results
    From NextCure
    Via GlobeNewswire
    < Previous 1 2 3 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.